lamivudine has been researched along with tyrosine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrilho, FJ; Kato, N; Lan, KH; Masaki, T; Omata, M; Ono-Nita, SK; Shiratori, Y | 1 |
| Chong, Y; Choo, H; Chu, CK | 1 |
| Fan, J; Liang, WF; Xie, YJ; Yang, DH; Zhao, NF | 1 |
| Hamada, K; Muramatsu, A; Nishioji, K; Oda, Y; Okuno, T; Shindo, M | 1 |
| Goto, T; Kato, N; Omata, M | 1 |
| Chan, AO; Lai, CL; Sum, SS; Wong, BC; Wong, DK; Yuan, HJ; Yuen, JC; Yuen, MF | 1 |
| Han, B; Wang, RS; Yang, ZJ; Zhang, H; Zhu, YF | 1 |
| Abdul, HM; Ansari, MA; Butterfield, DA; Nath, A; Opii, WO; Sultana, R | 1 |
| Cakir, N; Midilli, K; Pamuk, ON; Umit, H | 1 |
| Chatterjee, DK; Eisenhauer, BM; Gotte, M; Hecht, SM; Klarmann, GJ; Le Grice, SF; Pata, JD; Zhang, Y | 1 |
| Wu, F; Wu, MJ; Zhu, B; Zhu, SM; Zhuge, XL | 1 |
| Gao, YJ; Jin, B; Li, HW; Liu, ZW; Ma, XM; Meng, FP; Su, HB; Zhang, M; Zhao, JM | 1 |
| Alagozlu, H; Coskun, M; Koksal, B; Ozdemir, O; Yilmaz, A | 1 |
1 review(s) available for lamivudine and tyrosine
| Article | Year |
|---|---|
[YMDD motif and its significance].
Topics: Amino Acid Motifs; Asparagine; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Methionine; Mutation; Reverse Transcriptase Inhibitors; Reverse Transcription; RNA-Directed DNA Polymerase; Tyrosine | 2004 |
1 trial(s) available for lamivudine and tyrosine
| Article | Year |
|---|---|
Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection.
Topics: Adolescent; Adult; Amino Acid Motifs; Anti-HIV Agents; Aspartic Acid; DNA, Circular; DNA, Viral; Female; Follow-Up Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Isoleucine; Lamivudine; Male; Methionine; Middle Aged; Mutation; Placebos; Reverse Transcriptase Inhibitors; Tyrosine; Valine; Viral Load | 2005 |
11 other study(ies) available for lamivudine and tyrosine
| Article | Year |
|---|---|
YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection.
Topics: Amino Acid Sequence; Aspartic Acid; Base Sequence; Cell Line; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance; Genetic Variation; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunohistochemistry; Lamivudine; Male; Methionine; Middle Aged; Molecular Sequence Data; Reverse Transcriptase Inhibitors; Transfection; Tyrosine | 1999 |
The role of 2',3'-unsaturation on the antiviral activity of anti-HIV nucleosides against 3TC-resistant mutant (M184V).
Topics: Amino Acid Substitution; Anti-HIV Agents; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Lamivudine; Models, Molecular; Molecular Conformation; Mutation; Nucleosides; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tyrosine | 2003 |
PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine.
Topics: Adolescent; Adult; Amino Acid Motifs; Aspartic Acid; Base Sequence; Child; DNA-Directed DNA Polymerase; Drug Resistance; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Methionine; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Inhibitors; Tyrosine | 2002 |
The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartic Acid; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Male; Methionine; Middle Aged; Mutation; Predictive Value of Tests; Retrospective Studies; Treatment Outcome; Tyrosine | 2004 |
Detection of YMDD mutants using universal template real-time PCR.
Topics: Antiviral Agents; Aspartic Acid; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Methionine; Mutation; Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA; Tyrosine | 2006 |
Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)--2',3'-dideoxycytidine (ddC): relevance to HIV-dementia.
Topics: AIDS Dementia Complex; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Bridged-Ring Compounds; Caspase 3; Cerebral Cortex; Cytochromes c; Disease Progression; Gerbillinae; Humans; Lamivudine; Male; Mitochondria; Nerve Tissue Proteins; Neuroprotective Agents; Norbornanes; Oxidation-Reduction; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Inhibitors; Synaptosomes; Thiocarbamates; Thiones; Tyrosine; Zalcitabine | 2007 |
Successful treatment with adefovir of one patient whose cryoglobulinemic vasculitis relapsed under lamivudine therapy and who was diagnosed to have HBV virologic breakthrough with YMDD mutations.
Topics: Adenine; Amino Acid Motifs; Aspartic Acid; Cryoglobulinemia; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Methionine; Middle Aged; Mutation; Organophosphonates; Recurrence; Tyrosine; Vasculitis | 2006 |
Investigating the "steric gate" of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by targeted insertion of unnatural amino acids.
Topics: Amino Acid Substitution; Binding Sites; Cell-Free System; Cytidine Triphosphate; Deoxycytosine Nucleotides; Dideoxynucleotides; DNA; Escherichia coli; HIV Reverse Transcriptase; HIV-1; Hydrogen Bonding; Kinetics; Lamivudine; Models, Molecular; Protein Biosynthesis; Protein Engineering; Reverse Transcriptase Inhibitors; Transcription, Genetic; Tyrosine | 2007 |
Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment.
Topics: Adult; Aged; Alanine Transaminase; Amino Acids; Antiviral Agents; Aspartic Acid; China; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Isoleucine; Lamivudine; Logistic Models; Male; Methionine; Middle Aged; Mutation; Retrospective Studies; Tyrosine; Valine | 2012 |
Clinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients.
Topics: Adult; Age Factors; Antiviral Agents; Aspartic Acid; Carcinoma, Hepatocellular; China; DNA, Viral; Drug Therapy, Combination; End Stage Liver Disease; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Methionine; Middle Aged; Mutation; Retrospective Studies; Risk Factors; Secondary Prevention; Sex Factors; Tyrosine | 2014 |
Prevelance of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population.
Topics: Adenine; Adult; Aged; Amino Acid Motifs; Anti-HIV Agents; Antiviral Agents; Aspartic Acid; Case-Control Studies; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Methionine; Middle Aged; Mutation; Organophosphonates; Prognosis; Retrospective Studies; Turkey; Tyrosine | 2013 |